SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-035029
Filing Date
2022-06-08
Accepted
2022-06-08 16:22:23
Documents
2
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1646
2 POA DOCUMENT poa.txt EX-24 2048
  Complete submission text file 0001209191-22-035029.txt   5180
Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PFENEX INC. 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Chen Hubert C (Reporting) CIK: 0001622297 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38052 | Film No.: 221003785